Global Veterinary Antibiotics Market to surpass US$ 1.93 billion by 2030, Says Coherent Market Insights (CMI)

·4 min read
CMI
CMI

Seattle, Aug. 10, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global veterinary antibiotics market is estimated to be valued at US$ 1.43 billion in 2022 and is expected to exhibit a CAGR of 3.8% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Veterinary Antibiotics Market:

Major players operating in the market are focusing on adopting growth strategies such as technological advancements and new product approvals, which is expected to drive the market growth over the forecast period. For instance, in August 2018, Bayer launched i-COWNT BRD, a novel online comparison tool designed to help veterinarians make more informed treatment decisions for bovine respiratory disease (BRD). It is based on an independent meta-analysis comparing mixed treatments from BRD treatment studies. I-COWNT BRD simplifies scientific data analysis to enable veterinarians to select the most effective antibiotic for treatment.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2324

Key Market Takeaways:

The global veterinary antibiotics market is expected to exhibit a CAGR of 3.8% during the forecast period due to advances in pet medicine and surgery continue, there will be a increasing demand for appropriate antibiotics.

Among product type, anti-bacterial segment is expected to hold a dominant position over the forecast period, owing to benefits such as prevention and treatment of animal diseases, protection of public health, and increase in animal production.

On the basis of end-use, dairy farm segment is expected to hold a dominant position over the forecast period, owing to the use of antibiotics in food-producing animals has resulted in healthier, more productive animals; reduced incidence of disease and reduced morbidity and mortality in humans and animals; and the production of copious amounts of nutritious, high-quality, and inexpensive food for human consumption.

Competitive Landscape:

Key players operating in the global veterinary antibiotics market include Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi S.A., Vetoquinol S.A., Virbac, and Zoetis, Inc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2324

Market Segmentation:

  • Global Veterinary Antibiotics Market, By Product Type:

    • Anti-parasitic

    • Anti-bacterial

    • Non-steroidal anti-inflammatory drug

    • Others

  • Global Veterinary Antibiotics Market, By End-use:

    • Dairy Farm

    • Poultry Farm

    • Others

  • Global Veterinary Antibiotics Market, By Region:

    • North America

      • By Country

        • U.S.

        • Canada

    • Latin America

      • By Country

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • By Country

        • Germany

        • U.K.

        • France

        • Italy

        • Spain

        • Russia

        • Rest of Europe

    • Asia Pacific

      • By Country

        • China

        • India

        • Japan

        • Australia

        • South Korea

        • ASEAN

        • Rest of Asia Pacific

    • Middle East

      • By Country

        • GCC

        • Israel

        • Rest of Middle East

    • Africa

      • By Region/Country

        • South Africa

        • Central Africa

        • North Africa

Related Market Intelligence Reports:

Generic Sterile Injectables Market, by Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Antibiotics, and Others), by Therapeutic Application (Cancer, Metabolic Diseases, Cardiovascular Diseases, Central Nervous System Disease, Infectious Disorders, Musculoskeletal Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

Acute Bacterial Skin and Skin Structure Infections Market, by Drug Type (Oral & Parenteral Antibiotics {Vancomycin, Linezolid, Clindamycin, Ceftaroline, Daptomycin, Dalbavancin, Tedizolid, and Others (Rifampin, Doxycycline, Minocycline, and Trimethoprim-Sulfa Methoxazol, among others)}, and Topical Antibiotics {Hydrogen Peroxide, Fusidic Acid, Mupirocin, Retapamulin, and Povidone-Iodine}), by Infection Type (Hospital Acquired ABSSSI, and Community Acquired ABSSSI), by Route of Administration (Oral, Parenteral, and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedInTwitter

CONTACT: Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com